CAR-T Cell Therapies: An Overview of Clinical Studies Supporting Their Approved Use against Acute Lymphoblastic Leukemia and Large B-Cell Lymphomas

Chimeric Antigen Receptor (CAR)-T cell therapy is an exciting development in the field of cancer immunology, wherein immune T-cells from patients are collected, engineered to create ‘CAR’-T cells, and infused back into the same patient. Currently, two CAR-T-cell-based therapies, Tisagenlecleucel and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Aamir, Uddin, Shahab, Steinhoff, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312930/
https://www.ncbi.nlm.nih.gov/pubmed/32486160
http://dx.doi.org/10.3390/ijms21113906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312930/
https://www.ncbi.nlm.nih.gov/pubmed/32486160
http://dx.doi.org/10.3390/ijms21113906

Ejemplares similares